军事知识服务平台
New perspectives in hepatocellular carcinoma surveillance after hepatitis C virus eradication
摘要 Achieving a sustained virologic response(SVR)through direct-acting antivirals for hepatitis C virus(HCV)infection significantly reduces the long-term risk of hepatocellular carcinoma(HCC),particularly in patients with advanced fibrosis(F3)or cirrhosis(F4).However,despite this improvement,the risks associated with HCC and the optimal surveillance strategies for patients who have achieved SVR remain topics of debate.This controversy is compounded by challenges in reliably staging liver fibrosis non-invasively,especially at advanced fibrosis(F3),and the unclear cost-effectiveness,modality,frequency,and duration of HCC surveillance in indi-viduals with SVR but without cirrhosis.These factors contribute to significant variations in surveillance guidelines recommended by different professional societies.Therefore,there is a pressing need for an optimal surveillance strategy that is both simplified and cost-effective to facilitate wider adoption by clinicians.This review article evaluates the existing data,addresses ongoing controver-sies,and aims to provide new perspectives on HCC surveillance strategies for patients who have achieved SVR from HCV.
Author: Calvin Q.Pan Andrew J.Park James S.Park
作者单位: Center for Liver Diseases,Guangzhou Medical Research Institute of Infectious Diseases,Guangzhou Eighth People's Hospital,Guangzhou Medical University,Guangdong,P.R.China Division of Gastroenterology and Hepatology,Department of Medicine,NYU Grossman School of Medicine,New York,NY,USA Division of Hepatology,Department of Medicine,North Shore University Hospital and Donald Barbara Zucker School of Medicine at Hofstra/Northwell Health,Manhasset,NY,USA Northwell Center for Liver Disease and Transplantation,Northwell Transplant Institute,Northwell Health,Manhasset,NY,USA Feinstein Visiting Research Scholar Program,Feinstein Institutes for Medical Research,Manhasset,NY,USA
年,卷(期): 2024, 12(6)
机标分类号: S435.72 TP311 F224
在线出版日期: 2025年6月18日